AbbVie and DISCO Pharmaceuticals Sign Oncology Drug Discovery Deal Worth Up to $2.54 Billion

DISCO Pharmaceuticals (“DISCO”) announced a strategic collaboration and option-to-license agreement with AbbVie to discover and develop novel A...

November 20, 2026 | Friday | News
Cancer Research UK and Dewpoint Therapeutics Partner to Advance MYC-Targeting Cancer Drug into Phase 1/2a Trial

DPTX8743 is a potential first-in-class small molecule modulator of MYC condensates, targeting one of cancer’s most important and historically undrugg...

November 18, 2026 | Wednesday | News
Quotient Sciences Advances AI-Guided Drug Formulation to Shorten Clinical Development

Developing effective drug formulations remains a major challenge for biopharma companies, particularly for molecules with poor solubility or complex releas...

November 16, 2026 | Monday | Interaction
argenx to Acquire Unnatural Products for Up to US$1.15 Billion to Expand Oral Peptide Drug Development

Argenx to acquire UNP for $550 million upfront plus contingent value rights tied to development and regulatory milestones, for total potential value of up ...

November 10, 2026 | Tuesday | News
iDEL Therapeutics and Daiichi Sankyo Partner to Develop Multi-Drug Conjugates for Solid Tumours

iDEL Therapeutics announced that it has entered into a research collaboration with Daiichi Sankyo (TSE: 4568) to utilize iDEL’s synthetic shuttl...

November 10, 2026 | Tuesday | News
China Medical System Secures Singapore Approval for Lumirix Cream to Treat Vitiligo

China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Rxilient Medical received ...

November 05, 2026 | Thursday | News
Rakovina Therapeutics and Celvion Use AI to Identify Priority Cancer Indications for ATR Inhibitor Development

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF), a biopharmaceutical company advancing innovative cancer therapies through AI-powered ...

October 30, 2026 | Friday | News
Exogenus Therapeutics Leads €13 Million European Project to Advance EXO-101 for Osteoarthritis

ExoCordOA, a five-year project, led by Exogenus Therapeutics and backed by Horizon Europe, brings together ten organisations spanning biotechnology, clin...

October 30, 2026 | Friday | News
CellsBin Wins NCI SBIR Award to Advance Blood-Based Multiple Myeloma Test

CellsBin®, a biotechnology company pioneering Rare-Cell Biology™, announced that it has received a Direct-to-Phase II Small Business Innov...

October 29, 2026 | Thursday | News
Kos Biotechnology Partners Invests in Golden Age Health to Expand Rare Disease Drug Access in Asia

Golden Age Health is co-founded and chaired by Michel Vounatsos, former Biogen CEO and Merck President Kos Biotechnology Partners ("Kos"), a global ...

October 28, 2026 | Wednesday | News
Roche’s Divarasib Extends Survival in Phase 3 Trial for KRAS G12C-Mutated Lung Cancer

Divarasib monotherapy demonstrated superior efficacy over first-generation KRAS G12C inhibitors, lowering the risk of disease progression or death by 42%...

October 27, 2026 | Tuesday | News
Okomera Partners with Servier to Advance Cancer Drug Development Using Tumour Modelling Technology

Okomera reaches a key milestone in its industrial rollout with the first commercial installation of its integrated platform, combining hardware, softwa...

October 22, 2026 | Thursday | News
FDA Approves GSK and Ionis’ Hibsago for Chronic Hepatitis B Treatment

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK announced that the U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen) for t...

October 22, 2026 | Thursday | News
Anteris Technologies Secures German Regulatory Clearance for DurAVR Heart Valve Trial

Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) announced that it has received full regulato...

October 21, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close